Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
作者信息
Kwon Janice, Carey Mark, Goldie Sue, Kim Jane
出版信息
Obstet Gynecol. 2007 Oct;110(4):933; author reply 933-4. doi: 10.1097/01.AOG.0000285328.87105.c7.
Abstract
摘要
相似文献
1
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.1级子宫内膜腺癌手术治疗策略的成本效益分析
Obstet Gynecol. 2007 Oct;110(4):933; author reply 933-4. doi: 10.1097/01.AOG.0000285328.87105.c7.
2
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.1级子宫内膜腺癌手术治疗策略的成本效益分析
Obstet Gynecol. 2007 Jun;109(6):1388-95. doi: 10.1097/01.AOG.0000262897.21628.06.
3
Comment on "The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer".
Gynecol Oncol. 2004 Dec;95(3):776; author reply 776-7. doi: 10.1016/j.ygyno.2004.09.001.
4
The management of endometrial carcinoma.
Br J Hosp Med. 1996;55(6):308-10.
5
Does surgical staging of clinical Stage I endometrial carcinoma significantly alter adjuvant management?
J Obstet Gynaecol. 2004 Apr;24(3):289-91. doi: 10.1080/01443610410001660087.
6
Laparoscopic technology for the treatment of endometrial cancer.用于治疗子宫内膜癌的腹腔镜技术。
Int J Gynaecol Obstet. 2006 May;93(2):176-81. doi: 10.1016/j.ijgo.2006.02.013. Epub 2006 Mar 6.
7
Quality-of-life analysis in the management of endometrial cancer.
Am J Obstet Gynecol. 2005 May;192(5):1388-90. doi: 10.1016/j.ajog.2004.12.081.
8
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.中高危子宫内膜癌患者盆腔放疗与铂类联合化疗的随机 III 期试验：日本妇科肿瘤学组研究
Gynecol Oncol. 2008 Jan;108(1):226-33. doi: 10.1016/j.ygyno.2007.09.029. Epub 2007 Nov 9.
9
Endometrial cancer and recurrence with hormonal manipulation.子宫内膜癌与激素治疗后的复发
J Obstet Gynaecol. 2004 Feb;24(2):192-3. doi: 10.1080/01443610410001653416.
10
Management of stage 1 endometrial carcinoma. Postoperative radiotherapy is not justified in women with medium risk disease.I期子宫内膜癌的管理。对于中度风险疾病的女性，术后放疗不合理。
BMJ. 2001 Mar 10;322(7286):568-9. doi: 10.1136/bmj.322.7286.568.
Zotero 插件